Anne Greist MD in Indianapolis, Indiana

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Anne Greist MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 7113994948
NPI #: 1063477073
NPI Created On: 04/20/2006
NPI Last Updated Listed as: 09/08/2021
Primary Taxonomy Code: 207RH0003X
License Number:
01033362A
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Indian.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Blood test, clotting time
3. Anti-clotting management for patient taking warfarin
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Established patient office or other outpatient visit, typically 10 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Initial hospital inpatient care, typically 50 minutes per day
11. Subsequent hospital inpatient care, typically 25 minutes per day
12. Hospital discharge day management, more than 30 minutes
13. Injection, iron dextran, 50 mg
14. Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.